Ezetimibe )ethane-1 2-diamine hydrochloride but generally less than200 mg/mL)

but generally less than200 mg/mL) in in vitro studies

also known as TRPM8 antagonist 2 is a potent and selective TRPM8 antagonist

such as vascular endothelial growth factor receptor (VEGFR)-1

so called because it had unusual properties compared with other current systems known at the time of its discovery) ion current

Ezetimibe )ethane-1 2-diamine hydrochloride but generally less than200 mg/mL)Ezetimibe, also known as SCH 58235, is a drug that lowers plasma cholesterol levels. It acts by decreasing cholesterol absorption in the small intestine. It may be used alone when other cholesterol lowering medications are not tolerated, or together with statins (e. g., ezetimibe simvastatin) when statins alone do not control cholesterol. Ezetimibe is recommended as second line therapy for those intolerant of statins or unable to achieve target LDL